Rosario Giacomini, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1505 Post Rd E Ste 102, Westport, CT 06880 Phone: 203-221-3830 Fax: 203-254-0300 |
Ms. Anne Fuller Rutherford, APRN Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9 Old Hill Rd, Westport, CT 06880 Phone: 203-981-9001 Fax: 203-981-9001 |
Maryam Syed, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1505 Post Rd E, Westport, CT 06880 Phone: 203-221-3830 |
Kyle Custis, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 129 Kings Hwy N, Westport, CT 06880 Phone: 203-221-3030 |
Rachel Mann Knoll, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1505 Post Rd E, Westport, CT 06880 Phone: 203-221-3830 Fax: 203-254-0300 |
Dr. Jay Joseph Berkes, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 374 Post Rd E, Westport, CT 06880 Phone: 203-268-2501 |
Dr. Sachin Modi, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 830 Post Rd E, Westport, CT 06880 Phone: 203-291-3800 Fax: 203-291-3810 |
Dr. Christie L Jeffries, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 728 Post Rd E, Westport, CT 06880 Phone: 203-291-3800 Fax: 203-226-1204 |
Richard A Singer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 728 Post Rd E, Westport, CT 06880 Phone: 203-291-3800 Fax: 203-226-1204 |
News Archive
Some challenges associated with implementing the health law have some Democrats complaining about the law in public - something once unthinkable.
NeuroEM Therapeutics, Inc., a Phoenix-based medical device R&D company, announced today that it has begun a study with a premiere research university to test its Transcranial Electromagnetic Treatment (TEMT) in aged primates.
Researchers from Duke University Medical Center have identified a variation in a particular gene that increases susceptibility to early coronary artery disease.
PROLOR Biotech, Inc. today announced positive results from a preclinical toxicology study designed to assess the safety and tolerability of PROLOR's proprietary long-acting reversible-pegylation technology.
› Verified 3 days ago